AKBA On Other Exchanges
Symbol
Exchange
AKBA is not on other exchanges.

Executive Profile*

Michel Dahan

Senior VP & Chief Business Officer,Akebia Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

40--
As of Fiscal Year 2017

Background*

Mr. Michel Dahan has been the Chief Business Officer and Senior Vice President at Akebia Therapeutics, Inc. since October 09, 2015. Mr. Dahan served as Vice President of Business Operations at Akebia Therapeutics, Inc. until October 09, 2015. Mr. Dahan served as Vice President of Commercial at Akebia Therapeutics, Inc., since 2013. Mr. Dahan joined Akebia in 2013 and leads global marketing and commercialization activities. served as the Vice President of Commercial Development ...

Read Full Background

\

Corporate Headquarters*

245 First Street
Suite 1400
Cambridge, Massachusetts 02142

United States

Phone: 617-871-2098
Fax: 617-871-2099

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

Master's Degree
Université Pierre-et-Marie-Curie
Unknown/Other Education
Groupe HEC

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
William K. Heiden CEO, President & Director
AMAG Pharmaceuticals, Inc.
$1.7M
Stuart Paul President, CEO & Director
Rockwell Medical, Inc.
$484.6K
Compensation as of Fiscal Year 2018.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact AKEBIA THERAPEUTICS INC, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.